Evidence map›Paper›PMID 31591650›Full record

Trial reportEuropean journal of nutrition2020

A randomized placebo-controlled trial to investigate the effect of lactolycopene on semen quality in healthy males.

Elizabeth A Williams, Madeleine Parker, Aisling Robinson, Sophie Pitt, Allan A Pacey

Open access · hybridAbstract readRandomized Controlled Trial
In one paragraph

Trial report in European journal of nutrition, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 2 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 2 syntheses or guidelines pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Antioxidants for male subfertility.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Trial
  4. Review
  5. Review
  6. Lycopene in male infertility.Naunyn-Schmiedeberg's archives of pharmacology · 2025
    Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Elizabeth A WilliamsDepartment of Oncology and Metabolism, Faculty of Medicine Dentistry and Health, Medical School, The University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK. e.a.williams@sheffield.ac.uk.ORCID http://orcid.org/0000-0002-1431-7549
Madeleine ParkerDepartment of Oncology and Metabolism, Faculty of Medicine Dentistry and Health, Medical School, The University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
Aisling RobinsonDepartment of Oncology and Metabolism, Faculty of Medicine Dentistry and Health, Medical School, The University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
Sophie PittDepartment of Oncology and Metabolism, Faculty of Medicine Dentistry and Health, Medical School, The University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.
Allan A PaceyDepartment of Oncology and Metabolism, Faculty of Medicine Dentistry and Health, Medical School, The University of Sheffield, Beech Hill Road, Sheffield, S10 2RX, UK.ORCID http://orcid.org/0000-0002-4387-8871
University of Sheffield · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePoor sperm quality is a major contributor to infertility in heterosexual couples, but at present there are few empirical therapies. Several studies have examined the role of dietary factors and data from randomized controlled trials suggest that oral antioxidant therapy can improve some sperm parameters. Health benefits of lycopene supplementation have been proposed for a variety of health conditions and here we examine whether it can help improve sperm quality. This study aimed to investigate the effect of 14 mg daily lactolycopene for 12 weeks on semen quality in healthy men.

methodsSixty healthy male participants were recruited and randomized to this double-blind, placebo-controlled parallel study and received either 14 mg/d lactolycopene or a placebo for 12 weeks. The primary endpoint was a change in motile sperm concentration. Secondary endpoints were all other aspects of sperm quality, including the level of sperm DNA damage.

resultsFifty-six men completed the intervention and the level of plasma lycopene was significantly increased in the men randomized to receive lycopene supplementation. There was no significant change in the primary endpoint (motile sperm concentration) post-intervention (p = 0.058). However, the proportion of fast progressive sperm (p = 0.006) and sperm with normal morphology (p < 0.001) did improve significantly in response to lactolycopene intervention.

conclusionsSupplementation with 14 mg/d lactolycopene improves sperm motility and morphology in young healthy men. CLINICAL TRIAL REGISTRY NUMBER AND WEBSITE: ISRCTN33248724 http://www.isrctn.com/ISRCTN33248724.

Indexed as

AdultAntioxidantsDietary SupplementsDouble-Blind MethodHumansLycopeneMaleSemen AnalysisSpermatozoaYoung AdultAntioxidantsLycopeneFertilityLactolycopeneSperm morphologySperm motility

Identifiers

PMID31591650
PMCPMC7058571
OpenAlexW2977716037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.